{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:46:21Z","timestamp":1785858381661,"version":"3.56.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1097\/01.mph.0000174565.91343.43","type":"journal-article","created":{"date-parts":[[2005,7,12]],"date-time":"2005-07-12T06:59:36Z","timestamp":1121151576000},"page":"403-407","source":"Crossref","is-referenced-by-count":15,"title":["Antiphospholipid Syndrome With Catastrophic Bleeding and Recurrent Ischemic Strokes as Initial Presentation of Systemic Lupus Erythematosus"],"prefix":"10.1097","volume":"27","author":[{"given":"Vilmarie","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy L","family":"Kuntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A","family":"Smithson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William L","family":"Nichols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210227","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1046\/j.1365-2257.1999.00279.x","article-title":"Systemic lupus erythematosus presenting with haemorrhagic manifestation.","volume":"21","author":"Ayoub","year":"1999","journal-title":"Clin Lab Haematol"},{"key":"R2-14-20210227","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0049-0172(90)90021-7","article-title":"Antiphospholipid antibody syndrome: immunologic and clinical aspects.","volume":"20","author":"Sammaritano","year":"1990","journal-title":"Semin Arthritis Rheum"},{"key":"R3-14-20210227","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/rheumatology\/30.4.308","article-title":"Acquired hypoprothrombinaemia and lupus anticoagulant: response to steroid therapy.","volume":"30","author":"Hift","year":"1991","journal-title":"Br J Rheumatol"},{"key":"R4-14-20210227","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1177\/096120339600500501","article-title":"The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome.","volume":"5","author":"Gharavi","year":"1996","journal-title":"Lupus"},{"key":"R5-14-20210227","first-page":"372","article-title":"Transient lupus anticoagulant associated with prothrombin deficiency: unusual cause of bleeding in a 5-year-old girl.","volume":"16","author":"Humphries","year":"1994","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"R6-14-20210227","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0002-9343(87)90772-8","article-title":"Correction of hypoprothrombinemia by immunosuppressive treatment of the lupus anticoagulant-hypoprothrombinemia syndrome.","volume":"83","author":"Simel","year":"1987","journal-title":"Am J Med"},{"key":"R7-14-20210227","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/096120339600500212","article-title":"Immunology of antiphospholipid antibodies and their interaction with plasma proteins.","volume":"5","author":"Kandiah","year":"1996","journal-title":"Lupus"},{"key":"R8-14-20210227","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0038-1646306","article-title":"Prolonged bleeding time in patients with lupus anticoagulant.","volume":"68","author":"Orlando","year":"1992","journal-title":"Thromb Haemost"},{"key":"R9-14-20210227","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1365-2141.1982.tb01966.x","article-title":"An acquired coagulation inhibitor to factor II.","volume":"50","author":"Scully","year":"1982","journal-title":"Br J Haematol"},{"key":"R10-14-20210227","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2141.2003.04325.x","article-title":"Lupus anticoagulant associated with transient severe factor X deficiency: a report of two patients presenting with major bleeding complications.","volume":"121","author":"Ashrani","year":"2003","journal-title":"Br J Haematol"},{"key":"R11-14-20210227","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop.","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R12-14-20210227","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2007-1002434","article-title":"Deep vein thrombosis: prevalence of etiologic factors and results of management in 100 consecutive patients.","volume":"18","author":"Bick","year":"1992","journal-title":"Semin Thromb Hemost"},{"key":"R13-14-20210227","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome: clinical and laboratory features of 50 patients.","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine (Baltimore)"},{"key":"R14-14-20210227","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1177\/014107680209500705","article-title":"Antiphospholipid syndrome.","volume":"95","author":"Keswani","year":"2002","journal-title":"J R Soc Med"},{"key":"R15-14-20210227","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0268-960X(93)90006-P","article-title":"Haematological manifestations of systemic lupus erythematosus.","volume":"7","author":"Keeling","year":"1993","journal-title":"Blood Rev"},{"key":"R16-14-20210227","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2141.1989.tb04322.x","article-title":"Inhibition of phospholipid and platelet-dependent prothrombinase activity in the plasma of patients with lupus anticoagulants.","volume":"72","author":"Galli","year":"1989","journal-title":"Br J Haematol"},{"key":"R17-14-20210227","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood.V81.10.2618.2618","article-title":"Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism?","volume":"81","author":"Oosting","year":"1993","journal-title":"Blood"},{"key":"R18-14-20210227","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1172\/JCI118276","article-title":"Activation of cultured vascular endothelial cells by antiphospholipid antibodies.","volume":"96","author":"Simantov","year":"1995","journal-title":"J Clin Invest"},{"key":"R19-14-20210227","first-page":"817","article-title":"Antibody against oxidized low-density lipoprotein predicting myocardial infarction. Arch Intern Med. 1994;154:2605-2609.","volume":"155","author":"Puurunen","year":"1995","journal-title":"Erratum in Arch Intern Med"},{"key":"R20-14-20210227","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis.","volume":"339","author":"Salonen","year":"1992","journal-title":"Lancet"},{"key":"R21-14-20210227","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1055\/s-0037-1615892","article-title":"Antibody-mediated disruption of the annexin-V antithrombotic shield: a new mechanism for thrombosis in the antiphospholipid syndrome.","volume":"82","author":"Rand","year":"1999","journal-title":"Thromb Haemost"},{"key":"R22-14-20210227","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ajh.2830190308","article-title":"Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.","volume":"19","author":"Gastineau","year":"1985","journal-title":"Am J Hematol"},{"key":"R23-14-20210227","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/archinte.1984.00350150102029","article-title":"Thromboembolism in patients with the lupus-type circulating anticoagulant.","volume":"144","author":"Elias","year":"1984","journal-title":"Arch Intern Med"},{"key":"R24-14-20210227","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.STR.28.3.646","article-title":"Subdural hematoma and lupus anticoagulants.","volume":"28","author":"Moll","year":"1997","journal-title":"Stroke"},{"key":"R25-14-20210227","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/096120339700600110","article-title":"Catastrophic haemorrhage in a case of paediatric primary antiphospholipid syndrome and factor II deficiency.","volume":"6","author":"Hudson","year":"1997","journal-title":"Lupus"},{"key":"R26-14-20210227","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-3476(97)70291-9","article-title":"Transient lupus anticoagulants associated with hemorrhage rather than thrombosis: the hemorrhagic lupus anticoagulant syndrome.","volume":"130","author":"Becton","year":"1997","journal-title":"J Pediatr"},{"key":"R27-14-20210227","first-page":"345","article-title":"Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome: case report and review of literature.","volume":"82","author":"Vivaldi","year":"1997","journal-title":"Haematologica"},{"key":"R28-14-20210227","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/mva.2002.127336","article-title":"Successful management of life-threatening hemorrhage in a patient with synchronous lupus anticoagulant and factor VIII inhibitor.","volume":"36","author":"Brings","year":"2002","journal-title":"J Vasc Surg"},{"key":"R29-14-20210227","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/rheumatology\/40.5.585","article-title":"Diffuse muscular haemorrhage as presenting sign of juvenile systemic lupus erythematosus and lupus anticoagulant hypoprothrombinaemia syndrome.","volume":"40","author":"Yacobovich","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"R30-14-20210227","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1182\/blood.V61.4.684.684","article-title":"A mechanism for the hypoprothrombinemia of the acquired hypoprothrombinemia-lupus anticoagulant syndrome.","volume":"61","author":"Bajaj","year":"1983","journal-title":"Blood"},{"issue":"Suppl 1","key":"R31-14-20210227","first-page":"3","article-title":"Diagnosis of factor VIII versus nonspecific inhibitors.","volume":"30","author":"Goldsmith","year":"1993","journal-title":"Semin Hematol"},{"key":"R32-14-20210227","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0038-1649988","article-title":"Triplett DA, on behalf of the Subcommittee on Lupus Anticoagulants\/Antiphospholipid Antibodies of the ISTH. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants.","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"R35-14-20210227","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1067\/mtc.2002.126038","article-title":"Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.","volume":"124","author":"Bui","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R36-14-20210227","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1055\/s-0037-1613110","article-title":"Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.","volume":"87","author":"Rosenfeld","year":"2002","journal-title":"Thromb Haemost"},{"key":"R37-14-20210227","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-112-9-674","article-title":"Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus.","volume":"112","author":"Boumpas","year":"1990","journal-title":"Ann Intern Med"},{"key":"R39-14-20210227","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1161\/01.STR.29.11.2245","article-title":"Cerebrovascular ischemic events with high positive anticardiolipin antibodies.","volume":"29","author":"Verro","year":"1998","journal-title":"Stroke"},{"key":"R40-14-20210227","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1046\/j.1365-2141.2000.02069.x","article-title":"Guidelines on the investigation and management of the antiphospholipid syndrome.","volume":"109","author":"Greaves","year":"2000","journal-title":"Br J Haematol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mph.0000174565.91343.43","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:51:57Z","timestamp":1785855117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200507000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mph.0000174565.91343.43","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}